FDA approves the first Humira biosimilar
US regulators have issued a green light for the first biosimilar of AbbVie’s biologic Humira, the world second best-selling drug.
Read More
Tag: Amjevita
- KOALA trial opens to enrol patients for first‑in‑human KMCAR T‑cell therapy
- Pepaxti study supports use in wider myeloma population
- UCB reports positive outcomes for bimekizumab in psoriatic arthritis
- AstraZeneca wins US approval for first‑in‑class Baxfendy in hypertension
- Cellbxhealth partners with AdventHealth on CTC‑based monitoring in two major cancer studies
